Advanced Glaucoma Management with Microincisional Surgery
At Goldman Eye, we specialize in advanced, minimally invasive solutions for managing glaucoma — one of the leading causes of preventable blindness worldwide.
Under the care of our board-certified ophthalmic surgeons, we offer cutting-edge treatments such as Selective Laser Trabeculoplasty (SLT) and Microincisional Glaucoma Surgery (MIGS) to lower intraocular pressure (IOP) safely and effectively. In addition, we have the newest technology, Direct Selective Laser Trabeculoplasty by Alcon, which improves the accuracy and decreases the procedure time. We were the first Opthalmologists in South Florida to offer this technology.
Our goal is to protect and preserve your vision with the least invasive, most comfortable options available — helping patients throughout Palm Beach Gardens, Jupiter, Stuart, Martin County, and South Florida achieve better long-term eye health and freedom from the burden of daily eye drops.
Understanding Glaucoma and Eye Pressure
Glaucoma is a progressive disease that damages the optic nerve, often due to increased intraocular pressure (IOP).
If untreated, it can cause permanent vision loss. Unfortunately, glaucoma typically has no early symptoms, making regular screenings and proactive treatment essential.
Traditional management has focused on prescription eye drops or more invasive surgical procedures. However, today’s technology offers a new, gentler era of glaucoma care — led by SLT and MIGS.
Selective Laser Trabeculoplasty (SLT) – The First-Line Therapy for Glaucoma
Selective Laser Trabeculoplasty (SLT) is now considered the preferred first-line therapy for patients with open-angle glaucoma or ocular hypertension, as recommended by major clinical studies including the LiGHT Trial, published in The Lancet.
Unlike older laser techniques, SLT is non-thermal and restorative, meaning it lowers eye pressure without causing scarring or tissue damage.
How SLT Works
SLT applies ultra-short nanosecond pulses of laser light to the trabecular meshwork — the tissue responsible for draining fluid from the eye.
This gentle, selective photothermolysis triggers a natural biological response that improves fluid outflow and reduces IOP.
- No heat, no tissue damage: Unlike Argon Laser Trabeculoplasty (ALT), SLT preserves the trabecular meshwork and Schlemm’s canal.
- Stimulates natural healing: Promotes macrophage recruitment and cytokine release, restoring outflow function.
- Safe repeatability: Because SLT causes no structural damage, it can be repeated if necessary.
The procedure takes just minutes to perform in-office and is completely painless. Patients typically resume normal activities immediately after treatment.
Clinical Evidence Supporting SLT
The LiGHT Trial (The Lancet, 2019) compared SLT to eye drops as the initial treatment for open-angle glaucoma and ocular hypertension.
Key Findings:
- SLT achieved the same average IOP reduction as medication (from ~24.5 mmHg to ~18 mmHg).
- SLT eliminated or reduced the need for daily eye drops in the majority of patients.
- Patients reported improved convenience, fewer side effects, and better long-term control.
IOP Reduction Comparison (LiGHT & Katz et al. 2012 Studies):
| Treatment | Baseline IOP | Post-Treatment IOP |
|---|---|---|
| SLT | 24.5 mmHg | 18.2 mmHg |
| Medication | 24.7 mmHg | 17.7 mmHg |
These findings confirmed that SLT is equally effective as eye drops, with fewer risks and better patient compliance — making it an ideal first-line therapy.
Benefits of SLT Laser Therapy
- Effectively lowers IOP by 20–30%
- Eliminates or reduces need for eye drops
- Painless, non-invasive, and quick (typically 10 minutes)
- No recovery time required
- No scarring or tissue damage
- Repeatable as needed
SLT can be performed as a stand-alone procedure or in combination with other glaucoma surgeries.
Diagnostic and Therapeutic Synergy
SLT also provides valuable diagnostic insight.
If SLT successfully lowers IOP, it indicates that the main blockage lies in the trabecular meshwork. If not, the obstruction may exist elsewhere, guiding your doctor toward alternative therapies.
This dual function — both diagnostic and therapeutic — makes SLT an indispensable tool in comprehensive glaucoma management.
Microincisional Glaucoma Surgery (MIGS)
For patients requiring additional IOP reduction beyond SLT or medical therapy, Microincisional Glaucoma Surgery (MIGS) provides a minimally invasive alternative to traditional filtering procedures.
MIGS procedures use microscopic instruments and tiny incisions to enhance fluid drainage, lower eye pressure, and minimize recovery time — all with a superior safety profile compared to conventional surgeries like trabeculectomy.
MIGS Procedures Offered at Goldman Eye
We are proud to offer the full spectrum of FDA-approved MIGS procedures, allowing us to tailor each treatment to your unique anatomy and disease stage.
Combining SLT and MIGS
SLT and MIGS work synergistically.
SLT can be used before MIGS to assess trabecular outflow function or after MIGS to further reduce IOP without additional medication.
This layered approach allows Goldman Eye to create a personalized treatment plan that evolves with your disease stage and vision goals.
Why Choose Goldman Eye for Glaucoma Treatment
- Comprehensive Expertise: Our surgeons are highly skilled in medical, laser, and surgical glaucoma management.
- State-of-the-Art Technology: From diagnostic imaging to advanced MIGS instrumentation, we invest in precision and safety.
- Evidence-Based Care: We follow the latest global research — including The Lancet’s LiGHT Trial — to guide treatment decisions.
- Patient-Centered Approach: Every plan is individualized to reduce medication burden and preserve lifelong vision.
At Goldman Eye, you’re not just treated for glaucoma — you’re cared for by a team dedicated to protecting your sight with integrity and innovation.